Blog

Philadelphia, June 17, 2024 – Early diagnosis of hepatocellular carcinoma (HCC)—one of the most fatal malignancies—is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival

“[…] our current work has provided a novel strategy to enrich for a sub-population of cancer cells, with high basal levels of mitophagy.”   Credit: 2024 Mauro-Lizcano et al. “[…] our current work has provided a novel strategy to enrich for a sub-population of cancer

FOR IMMEDIATE RELEASE Credit: Yasuyoshi Kimura, Ph.D. FOR IMMEDIATE RELEASE In studies with genetically engineered mice, Johns Hopkins Medicine researchers say they have identified a potentially new biological target involving Aplp1, a cell surface protein that drives the spread of Parkinson’s disease-causing alpha-synuclein. The findings,

PLYMOUTH MEETING, PA [June 17, 2024] — The National Comprehensive Cancer Network® (NCCN®) today announced new recognitions for the award-winning library of NCCN Guidelines for Patients® and NCCN Patient Webinars. The NCCN Guidelines for Patients: Colon Cancer earned a Gold Award from Hemes Creative Awards

Things aren’t always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic. Some of the pancreatic cells appear to have lost their identity. It’s as if they forget what they are.  Credit: Vakoc

KEY TAKEAWAYS Credit: Tanmoy Saha, Brigham and Women’s Hospital KEY TAKEAWAYS Lung cancer is the most diagnosed cancer and the leading cause of cancer death globally, representing an urgent need for new and improved treatment options. Researchers from Brigham and Women’s Hospital developed a new

“Elucidating the function of Erk5 in cancer […] will contribute to a better understanding of cancer pathogenesis and the development of novel therapeutic strategies.” Credit: 2024 Horie and Hinoi. “Elucidating the function of Erk5 in cancer […] will contribute to a better understanding of cancer

Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at Memorial Sloan Kettering Cancer Center (MSK). Credit: Memorial Sloan Kettering Cancer Center Periods of fasting reprogram the immune system’s natural killer

Today, the European Haematology Association (EHA) has awarded its prestigious and exclusive Bilateral Collaborative Grants in Madrid, as part of the opening ceremony of the EHA Annual Congress. Among the selected projects is the one proposed by Dr Biola M. Javierre, head of the 3D

Worldwide, a majority of babies — approximately 75% — drink infant formula in their first six months of life, either as a sole source of nutrition or as a supplement to breastfeeding. But while formula provides essential food for growing babies, it currently does not